Primarily intended for physicians and health care professionals who are treating obese patients, this book explores current and future options for drug treatment of obesity puts them into perspective against available alternative treatments. Distinguished scientists and clinical investigators provide reviews of each individual topic, covering a wide range of subjects from pathophysiology of obesity to the benefits of weight loss. The core sections on pharmacotherapy deal with currently available drugs and drugs in pre-clinical development, complemented with sections on non-drug treatment and general therapeutic aspects to provide an integrated view of therapeutic approaches to the treatment of obesity and its associated syndromes.2000; Wirth and Krause 2001), patients were randomized to placebo or sibutramine for maintenance of weight loss for up to 18 months. ... Patients will report that athe medication is not working, since I am no longer losing weight. ... FIGURE 12.6 Mean change in body weight during the study Pharmacotheraphy of obesity 276.
|Title||:||Pharmacotherapy of Obesity|
|Author||:||Karl G. Hofbauer, Ulrich Keller, Olivier Boss|
|Publisher||:||CRC Press - 2004-06-14|